The greater estimated expense associated with USGFNAB may still be a reasonable expenditure to achieve an additional correct diagnosis, but that is for individual practices and providers to decide.
Kauf
Teresa L
TL
D044963:Biopsy, Fine-Needle / Q000191:economics* / Q000379:methods; D003362:Cost-Benefit Analysis; D003663:Decision Trees; D006801:Humans; D010818:Practice Patterns, Physicians'; D013673:Technology Assessment, Biomedical; D016606:Thyroid Nodule / Q000175:diagnosis / Q000473:pathology*; D018084:Ultrasonography, Interventional / Q000191:economics*